Conference abstract · 15 Apr 2013
Case reportPublished 2018
Anti-Thrombotic Drug Problems
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Antithrombotic therapy is associated with significant medical complications, particularly bleeding of the anticoagulants used long term by the oral route, warfarin is the safest because the dosage is regularly adjusted according to the results of INR tests. There have recently come into common use a number of oral anti-coagulants that are given as a fixed dose with no monitoring. These include rivaroxaban, dabigatran, apixaban and edoxaban and a number of blockers of the coagulation cascade, such as Factor Xa and thrombin in inhibitors. Injected heparin and low-molecular heparins are mostly used for emergency or initial circumstances. The side effects of adminstration of such drugs are haematuria, melena, epistaxis, ecchymosis, hematemesis, haemoptysis, haemorrhagic stroke and heavy periods in women.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 16 Dec 2024
Aspirin as an Anti-Thrombotic: A Comprehensive Overview
Research article · 30 Apr 2015
Novel synthesis of Ticagrelor, an anti-thrombotic agent
Commentary · 2 Feb 2023
Importance of Anti-Thrombotic Drugs in Preventing Blood Clots
Commentary · 29 Jul 2022
Drug Interactions of Anti-Thrombotic Drugs and its Side Effects
More from this journal
The newest in Cardiovascular Pharmacology: Open Access.
Article · 28 Jun 2025
Advances in Antiplatelet Therapy for Secondary Prevention of Myocardial Infarction
Article · 28 Jun 2025
Beta Blockers and Their Expanding Role in Cardiovascular Disease
Article · 28 Jun 2025
Emerging Role of PCSK9 Inhibitors in Lipid Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- SubjectCardiology
- BylineArticles whose byline prints “Mark I M Noble”

